EGFR875-889-specific CD4 T cells can be detected in the peripheral blood of HNSCC patients, and was shown to react against tumor cells expressing EGFR as well as other ErbB/HER family members (HER-2, HER-3) and c-kit, which have homologous peptide sequences. Here, CD4 is linked to neoplasm.